Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

UroGen Pharma Ltd. closes a strategic investment agreement with IntraGel to enhance its oncology pipeline. The company aims to utilize IntraGel's biodegradable gel platform for future oncology products.

PUBLIC · URGNAug 20, 2026•about 5 hours ago

Round Type

Corporate Round

PrincetonBiotechnologyHealthcare

Description

UroGen Pharma Ltd. announced a strategic collaboration with IntraGel, gaining access to their SRGel technology for localized drug delivery. This agreement enhances UroGen's capabilities in developing oncology products. The collaboration includes an equity investment agreement to support the development of innovative therapies

Company Information

Company

UroGen Pharma

Location

400 Alexander Park Drive

Princeton, New Jersey, United States

About

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.

Don't miss UroGen Pharma's next move

Get an email the moment UroGen Pharma raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Predictive Intelligence
Strategic

ML-powered predictions for UroGen Pharma's next move

Learn about Strategic plan

UroGen Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.